Xiao Lin
- Cancer Research top 2%
- MicroRNA in disease regulation 25
- Cancer-related molecular mechanisms research 13
- Nephrology top 5%
- Molecular Biology top 10%
- Extracellular vesicles in disease 23
- Circular RNAs in diseases 10
- Epigenetics and DNA Methylation 6
- Genetics top 10%
-
- Cardiovascular Disease and Adiposity 8
-
- Adipose Tissue and Metabolism 6
-
- Adipokines, Inflammation, and Metabolic Diseases 5
- Partner nations
- ChinaUnited KingdomFrance
In The Last Decade
Xiao Lin
60 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 104
- Cancer Research 697
- Nephrology 193
- Molecular Biology 1.1k
- Genetics 117
- Aging 15
Countries citing papers authored by Xiao Lin
This map shows the geographic impact of Xiao Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiao Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiao Lin more than expected).
Fields of papers citing papers by Xiao Lin
This network shows the impact of papers produced by Xiao Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiao Lin. The network helps show where Xiao Lin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiao Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 4 | |
| 6 | 2024 | 3 | |
| 7 | 2023 | 0 | |
| 8 | 2023 | 4 | |
| 9 | 2023 | 10 | |
| 10 | 2022 | 16 | |
| 11 | 2022 | 15 | |
| 12 | 2021 | 25 | |
| 13 | 2021 | 15 | |
| 14 | 2020 | 12 | |
| 15 | 2020 | 43 | |
| 16 | 2020 | 27 | |
| 17 | 2020 | 20 | |
| 18 | 2019 | 70 | |
| 19 | 2019 | 128 | |
| 20 | 2016 | 51 |
About Xiao Lin
Xiao Lin is a scholar working on Cancer Research, Health Informatics and Nephrology, having authored 64 papers that have together received 1.7k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (25 papers), Extracellular vesicles in disease (23 papers), Cancer-related molecular mechanisms research (13 papers), Circular RNAs in diseases (10 papers), Cardiovascular Disease and Adiposity (8 papers), Epigenetics and DNA Methylation (6 papers), Adipose Tissue and Metabolism (6 papers) and Adipokines, Inflammation, and Metabolic Diseases (5 papers). The work is most often cited by research in Cancer Research (697 citations), Nephrology (193 citations) and Molecular Biology (1.1k citations). Xiao Lin has collaborated with scholars based in China, United Kingdom and France. Frequent co-authors include Ling‐Qing Yuan, Jia‐Yu Zhong, Feng Xu, Su‐Kang Shan, Feng Wu, You‐Shuo Liu, Junkun Zhan, Fu‐Xing‐Zi Li, Bei Guo and Xiao‐Bo Liao. Their work appears in journals such as PLoS ONE, Scientific Reports and Endocrinology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.